Samsung Biologics Co.,Ltd. (KRX:207940)
South Korea · Delayed Price · Currency is KRW 1,219,000
-58,000 (-4.54%)
Last updated: Oct 8, 2026, 3:00 PM KST
Samsung Biologics Market Cap
Samsung Biologics has a market cap or net worth of 56.37 trillion as of October 8, 2026. It is the 592nd most valuable company in the world and the 8th biggest in South Korea. Its market cap has decreased by 21.51% in one year.
Market Cap
56.37T
Enterprise Value
55.39T
Revenue
5.12T
Global Rank
Country Rank
#8 South Korea
PE Ratio
28.71
ChartMarket Cap Chart
Since November 10, 2016, Samsung Biologics's market cap has increased from 9.53T to 56.37T, an increase of 491.60%. That is a compound annual growth rate of 19.64%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2026 | 56.46T | -28.04% |
| Dec 30, 2025 | 78.46T | 16.17% |
| Dec 30, 2024 | 67.54T | 24.87% |
| Dec 28, 2023 | 54.09T | -7.43% |
| Dec 29, 2022 | 58.43T | -2.20% |
| Dec 30, 2021 | 59.75T | 9.32% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Nov 10, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Celltrion | 41.03T |
| ALTEOGEN | 16.78T |
| Samsung Epis Holdings | 8.46T |
| HLB Co., Ltd. | 6.07T |
| SK Biopharmaceuticals | 5.69T |
| SK bioscience | 2.87T |
| LigaChem Biosciences | 2.70T |
| ABL Bio | 2.69T |